Search
Close this search box.

New evidence on the association between endometriosis and traumatic and stressful experiences

From left to right, researchers Dora Koller and Marina Mitjans. The Institute of Biomedicine (IBUB) and University of Barcelona has participated in an international study that has found new evidence linking traumatic experiences and stressful events with endometriosis, a chronic systemic inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus. They show

Maternal stress during pregnancy could leave traces in the placenta that could affect the baby’s development

Maternal stress could leave epigenetic imprints on genes in the placenta associated with cortisol — a necessary hormone for foetal development — and this would affect the baby’s development from very early stages, as stated in a paper published in the journal European Neuropsychopharmacology. The study suggests that a mother’s emotional wellbeing during pregnancy is

La Marató 2023 supports IBUB research studies on sexual and reproductive health

The 8.2 million euros raised by La Marató 2023 will help to promote 26 research projects on sexual and reproductive health led by 52 teams. These resources will be decisive in the coming years to find more answers to problems that affect three million people only in Catalonia, with 211,000 new cases each year, especially

IBUB RESEARCH DAY. November 4, 2024. Aula Magna, Historic Bulding, UB.

The annual meeting of IBUB researchers will take place on November 4 in the emblematic hall of the historic building of the University of Barcelona, the Aula Magna. The day will start with a keynote speaker of honor, Alexandra Avgustinova (IRSJD/IRB), followed by the presentation of the research lines of the new members of the

IBUB researchers design a drug capable of acting simultaneously against three different therapeutic targets

Study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new pharmacological tool capable of simultaneously administering three oligonucleotide-based drugs, each acting against a different therapeutic target within the cell. The paper, published in the journal Bioorganic Chemistry, presents a proof-of-concept of this innovative triple-targeting compound, which

IBUB scientists consolidate their position in the top 2% of scientists with the highest impact worldwide.

Recently Stanford University has again updated the databases of authors across all of science updated with standardized citation indicators. They have created a publicly available database of top-cited scientists that provides standardized information on citations, h-index, co-authorship adjusted hm-index, citations to papers in different authorship positions and a composite indicator (c-score). Separate data are shown

Decipher new molecular mechanisms related to biological tissue regeneration

A study published in The EMBO Journal opens new perspectives to better understand how the molecular mechanisms involved in regenerative medicine work. The study focuses on tumour necrosis factor-α (TNF-α) and its receptors TNFR, molecules of key interest in biomedicine due to their involvement in multiple diseases such as obesity related to type 2 diabetes

Researchers identify sex differences in genetic vulnerability to psychotic disorders

A team of researchers from the IBUB, University of Barcelona and the Centre for Biomedical Research in the Mental Health Network (CIBERSAM) has published a pioneering study that reveals significant findings in the field of genetic psychiatry from the perspective of separate gender analysis. Firstly, the paper confirms the existence of a shared genetic vulnerability between schizophrenia and

Emerging Leaders in Biomedicine

An event specifically tailored for advanced postdoctoral researchers and junior Group Leaders who are at the forefront of the vibrant biomedical community of the Barcelona area. The Emerging Leaders in Biomedicine symposium is now a key meeting point for the next generation of CancerResearch leaders. It aims to build a network of new group leaders